Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Individualised dosing of commonly used anti-cancer agents

Drug-drug interactions: Focus on acid-suppressive agents


30 Sep 2019


Individualised dosing of commonly used anti-cancer agents


Cytotoxic Therapy

Tumour Site

Oesophageal Cancer;  Gastric Cancer;  Non-Small Cell Lung Cancer;  Colon and Rectal Cancer


Ron Mathijssen


R.H. Mathijssen

Author affiliations

  • Medical Oncology, Erasmus MC Daniel den Hoed Cancer Center, 3075 EA - Rotterdam/NL


Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.